Area of research
Genetics · Infectious Diseases
Research interest
Research interests include Inflammatory Bowel Disease, Clostridium difficile and Clostridium perfringens research, Microscopic Colitis, and Gastrointestinal disorders and treatments.
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease
Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients
Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis
First Case of Refractory Colitis Caused by Ocrelizumab
African Ancestry Proportion Influences Ileal Gene Expression in Inflammatory Bowel Disease
Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience
Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>Infection
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease
The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses
Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans
Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report
Ulcerative Colitis: Update on Medical Management
Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile
Fecal Microbiota Transplant Protocol for<i>Clostridium Difficile</i>Infection
Diverticulitis after Fecal Microbiota Transplant for C. difficile Infection